Aspira Women's Health Inc.
AWH
$0.185
-$0.0018-0.96%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -2.33% | -1.21% | 4.46% | 11.85% | 16.43% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -2.33% | -1.21% | 4.46% | 11.85% | 16.43% |
Cost of Revenue | -3.60% | -3.54% | -8.82% | 0.80% | 2.88% |
Gross Profit | -1.40% | 0.57% | 16.31% | 21.72% | 28.95% |
SG&A Expenses | -13.00% | -23.21% | -29.40% | -31.79% | -35.21% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -10.49% | -21.10% | -28.56% | -28.78% | -32.40% |
Operating Income | 14.27% | 28.50% | 38.65% | 39.46% | 43.39% |
Income Before Tax | 18.67% | 24.99% | 45.80% | 44.15% | 46.89% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 18.67% | 24.99% | 45.80% | 44.15% | 46.89% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 18.67% | 24.99% | 45.80% | 44.15% | 46.89% |
EBIT | 14.27% | 28.50% | 38.65% | 39.46% | 43.39% |
EBITDA | 13.84% | 28.28% | 38.63% | 39.58% | 43.64% |
EPS Basic | 42.91% | 44.56% | 58.04% | 52.58% | 53.68% |
Normalized Basic EPS | 43.39% | 44.87% | 52.90% | 48.03% | 51.05% |
EPS Diluted | 42.96% | 44.66% | 58.10% | 52.64% | 54.36% |
Normalized Diluted EPS | 43.39% | 44.87% | 52.90% | 48.03% | 51.05% |
Average Basic Shares Outstanding | 44.24% | 35.73% | 26.73% | 18.77% | 15.04% |
Average Diluted Shares Outstanding | 44.24% | 35.73% | 26.73% | 18.77% | 15.04% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |